Company profile: ViroGates
1.1 - Company Overview
Company description
- Provider of suPARnostic blood test products for better triaging in hospitals, primarily used in emergency departments for risk stratification to improve patient care, reduce healthcare costs, and empower clinical staff.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ViroGates
Genomind
HQ: United States
Website
- Description: Provider of neuropsychiatry-focused precision medicine solutions, including pharmacogenetic (PGx) testing to personalize medication dosing and choices, software to identify gene–drug and drug–drug interaction risks and suggest safer alternatives, expert consults for staff training and patient-specific consultations, population health risk stratification, and in-person, virtual, and self-paced education.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomind company profile →
GeneDx
HQ: United States
Website
- Description: Provider of genomic diagnostics and data science solutions using artificial intelligence and machine learning to deliver personalized, actionable insights that improve health outcomes. Offers XomeDxXpress rapid whole exome sequencing (provisional results in 7 days, full report in 2 weeks), whole genome sequencing with optional trio testing, and genetic counseling services for patients and healthcare providers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneDx company profile →
Cygnus Technologies
HQ: United States
Website
- Description: Provider of generic kits, immunoassay reagents, and antibody and assay development services to pharmaceutical and biotechnology industries. Specializes in custom antibody and assay development for host cell protein detection in recombinant pharmaceuticals and supplies specialized analytical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cygnus Technologies company profile →
Cergentis
HQ: The Netherlands
Website
- Description: Provider of services and kits based on proprietary Targeted Locus Amplification (TLA) technology, enabling cost-effective complete sequencing of relevant genes and genomic loci and providing genetic characterization and quality control (QC) to support the development of advanced, safe and effective therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cergentis company profile →
Linkage Biosciences
HQ: United States
Website
- Description: Provider of molecular diagnostic products that improve and expedite complex genetic testing, initially focused on diagnostic products for solid organ and hematopoietic stem cell transplantation, including human leukocyte antigen testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Linkage Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ViroGates
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ViroGates
2.2 - Growth funds investing in similar companies to ViroGates
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ViroGates
4.2 - Public trading comparable groups for ViroGates
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →